JGLYX
Price
$18.92
Change
-$0.39 (-2.02%)
Updated
Feb 3 closing price
Net Assets
2.48B
VSGIX
Price
$88.54
Change
+$2.94 (+3.43%)
Updated
Feb 3 closing price
Net Assets
39.31B
Interact to see
Advertisement

JGLYX vs VSGIX

Header iconJGLYX vs VSGIX Comparison
Open Charts JGLYX vs VSGIXBanner chart's image
JPMorgan Small Cap Growth R4
Price$18.92
Change-$0.39 (-2.02%)
VolumeN/A
Net Assets2.48B
Vanguard Small Cap Growth Index I
Price$88.54
Change+$2.94 (+3.43%)
VolumeN/A
Net Assets39.31B
JGLYX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
JGLYX vs. VSGIX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGLYX is a StrongBuy and VSGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 39.3B vs. JGLYX (2.48B). VSGIX pays higher dividends than JGLYX: VSGIX (0.53) vs JGLYX (0.17). JGLYX was incepted earlier than VSGIX: JGLYX (9 years) vs VSGIX (26 years). JGLYX (1.00) is less costly to investors than VSGIX (0.06). JGLYX is a more actively managed with annual turnover of: 48.00 vs. VSGIX (21.00). JGLYX has a lower initial minimum investment than VSGIX: JGLYX (0) vs VSGIX (5000000). VSGIX annual gain was more profitable for investors over the last year : 8.94 vs. JGLYX (0.57). VSGIX return over 5 years is better than : 9.46 vs. JGLYX (-31.10).
JGLYXVSGIXJGLYX / VSGIX
Total Expense Ratio0.990.061,650%
Annual Report Gross Expense Ratio1.000.061,667%
Fund Existence9 years26 years-
Gain YTD5.5804.189133%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B39.3B6%
Annual Yield % from dividends0.170.5332%
Returns for 1 year0.578.946%
Returns for 3 years18.7737.3050%
Returns for 5 years-31.109.46-329%
Returns for 10 yearsN/A205.81-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIVRX35.940.48
+1.35%
Thornburg International Equity R5
CVMRX25.310.28
+1.12%
Calvert Emerging Markets Equity R6
MBXBF0.16N/A
N/A
Microbix Biosystems Inc.
FRACF2.14N/A
N/A
Foraco International, Marseille
BRWUX27.17-0.51
-1.84%
MFS Blended Research Growth Eq R4